BioCopy expands corporate portfolio with acquisition of Perspix Biotech GmbH

Basel, April 9, 2024
BioCopy AG announced the acquisition of Perspix Biotech GmbH.

Founded in 2021 and based in Frankfurt am Main, Germany, Perspix Biotech with its end-to-end automated platform roPROTix combines artificial intelligence and robotics for the discovery and development of next-generation multispecific biotherapeutics. As part of BioCopy AG, Perspix Biotech GmbH will be renamed as BioCopy Analytix GmbH and provide analytical and other services to the company group.